Update on the Role of FeNO in Asthma Management
Diagnostics, 2023 Asthma is a heterogenous disorder characterized by presence of different phenotypes and endotypes. Up to 10% of the individuals suffer from severe asthma and are at increased risk of morbidity and mortality. Fractional exhaled nitric oxide (FeNO) is a cost-effective, point of care biomarker that is used to detect type 2 airway inflammation.
Muhammad Adrish +2 more
exaly +5 more sources
FENO AND ATOPY IN PEDIATRIC ASTHMA [PDF]
Romanian Journal of Pediatrics, 2015 Objectives. The aim of this study was to determine the manner in which the level of exhaled nitric oxide (FENO) infl uences the atopic status in children with asthma. Methods.
Cristiana Stanciulescu +6 more
doaj +2 more sources
A pathophysiological approach for FeNO: A biomarker for asthma
Allergologia Et Immunopathologia, 2015 The present review is focused on literature concerning the relevance of fractional exhaled nitric oxide (FeNO) in clinical practice from a pathophysiological point of view. There is increasing evidence that asthma is a heterogeneous pathological condition characterised by different phenotypes/endotypes related to specific biomarkers, including FeNO ...
Giorgio Ciprandi +1 more
exaly +3 more sources
CORRELATION BETWEEN FENO VALUE AND ASTHMA SEVERITY [PDF]
Romanian Journal of Pediatrics, 2014 Objective. The purpose of this study is to assess the correlation between the FeNO (fractional exhaled nitric oxide) value and asthma severity. Material and method.
Eugenia Buzoianu +2 more
doaj +2 more sources
Azithromycin on serum FeNO, IgE, and eosinophil levels in bronchiectasis patients [PDF]
Caspian Journal of Internal MedicineBackground: Azithromycin, a macrolide antibiotic with notable anti-inflammatory properties, is widely used in the treatment of bronchiectasis. This study aimed to assess changes in serum fractional exhaled nitric oxide (FeNO), immunoglobulin E (IgE), and
Niloofar Keikhaei +3 more
doaj +2 more sources
Clinical Features of Chronic Obstructive Pulmonary Disease with High Fractional Exhaled Nitric Oxide [PDF]
Tuberculosis and Respiratory Diseases, 2020 Background The fractional exhaled nitric oxide (FENO) test is useful in asthma patients. However, a few studies on its usefulness in chronic obstructive pulmonary disease (COPD) patients have been reported.
Seong Ahn +6 more
doaj +1 more source
A Pilot Randomized Trial of As-Needed Budesonide-Formoterol for Stepping Down Controller Treatment in Moderate Asthma with Complete Remission [PDF]
Tuberculosis and Respiratory Diseases, 2022 Background The use of low-dose inhaled corticosteroid-formoterol as reliever monotherapy has recently been recommended in the asthma treatment guidelines.
Narongwit Nakwan +2 more
doaj +1 more source
Fractional exhaled nitric oxide and forced expiratory flow between 25% and 75% of vital capacity in children with controlled asthma [PDF]
Korean Journal of Pediatrics, 2012 PurposeFractional exhaled nitric oxide (FeNO) and forced expiratory flow between 25% and 75% of vital capacity (FEF25-75) are not included in routine monitoring of asthma control.
Ji-Yong Yoon +4 more
doaj +1 more source
Antioxidants, 2023 Background: Fractional exhaled nitric oxide (FeNO) is a biomarker of airway inflammation associated with airway hyper-responsiveness and type-2 inflammation.
Tommaso Pianigiani +10 more
doaj +1 more source
Complete Series of {FeNO}8, {FeNO}7, and {FeNO}6 Complexes Stabilized by a Tetracarbene Macrocycle
Journal of the American Chemical Society, 2016 Use of a macrocyclic tetracarbene ligand, which is topologically reminiscent of tetrapyrrole macrocycles though electronically distinct, has allowed for the isolation, X-ray crystallographic characterization and comprehensive spectroscopic investigation of a complete set of {FeNO}(x) complexes (x = 6, 7, 8).
Kupper, Claudia +4 more
openaire +6 more sources